Skip to main content
Signal8

Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection

$STVNPress releaseOct 27, 2026, 7:00 AM ETRead the release

Stevanato Group announced a collaboration with Aptar Pharma to provide system-level testing data pairing Stevanato's EZ-fill Nexa and Alba glass syringes with Aptar's elastomer components for pre-filled syringe configurations. The work targets sensitive biologics and high-concentration injectables, covering 1 mL long and 2.25 mL syringe formats and testing designed to support USP <382> compliance.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.